Benchmark Maintains Buy on MaxLinear, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst David Williams maintains a Buy rating on MaxLinear (NASDAQ:MXL) but lowers the price target from $28 to $22.

July 25, 2024 | 11:53 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Benchmark analyst David Williams maintains a Buy rating on MaxLinear but lowers the price target from $28 to $22.
The Buy rating suggests continued confidence in MaxLinear's prospects, but the lowered price target indicates some caution about near-term performance. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100